Fake drugs: A survey of healthcare providers in Lagos State, Nigeria.

Simple item page
dc.contributor.authorJoda, A.E.
dc.contributor.authorAmadi, C.
dc.contributor.authorAdebayo, O.I.
dc.contributor.authorMaji, Y.I.
dc.contributor.authorUchem, C.
dc.contributor.authorOlih, H.
dc.date.accessioned2019-12-09T13:44:19Z
dc.date.available2019-12-09T13:44:19Z
dc.date.issued2017
dc.descriptionStaff publicationsen_US
dc.description.abstractBackground: Faking and counterfeiting occurs throughout the world with claims that it is more common in some developing countries with weak regulatory programs. It is estimated that more than 10% of drugs worldwide are counterfeit, with up to 50% in some countries. Heightening vigilance and awareness of counterfeiting is one measure for combating faking. Rationale: The aim of this study was to document perceptions of various healthcare providers regarding the problem of drugs faking/counterfeiting including perceived levels, affected drugs, implications, and measures to control; thus, this study aims to provide empirical data on the perception of healthcare providers regarding counterfeit drugs and their effect on public health/safety. Materials and Methods: Ethical approval was obtained and pretested questionnaires were administered to consenting healthcare providers in six local government areas in Lagos. The collected data was sorted and entered into Microsoft Excel, following which analysis was carried out. Results are presented as tables and charts. Results: Respondents believed that the problem of fake/counterfeit drugs is common with a modal faking range of 41–50% of drugs in the country. Anti-infectives, anti-malarials, and analgesics were reported to be the most implicated drugs. Many believed that faking/counterfeiting of drugs can be surmounted by the promulgation and enforcement of appropriate legislation and closure of open drug markets. Conclusions: It can be concluded that respondents are aware of the challenges posed by counterfeit drugs and if empowered can serve as a tool in its eradication. It is recommended that appropriate modalities to review the existing laws and close open drug markets be put in place.en_US
dc.description.sponsorshipThe study was sponsored by the Pharmaceutical Society of Nigeria (PSN)en_US
dc.identifier.citationJoda AE, Amadi C, Adebayo OI, Maji YI, Uchem C and Olih H. (2017). Fake drugs: A survey of healthcare providers in Lagos State, Nigeria. Niger J Basic Clin Sci.,14:137-42.en_US
dc.identifier.issn0331-8540
dc.identifier.urihttps://ir.unilag.edu.ng/handle/123456789/7049
dc.language.isoenen_US
dc.publisherNigerian Journal of Basic and Clinical Sciencesen_US
dc.relation.ispartofseriesNiger J Basic Clin Sci.;Vol.14
dc.subjectCommunity pharmacistsen_US
dc.subjectCounterfeit drugsen_US
dc.subjectFake drugsen_US
dc.subjectPPMVLen_US
dc.subjectPrivate physicianen_US
dc.subjectPerceptionsen_US
dc.subjectResearch Subject Categories::PHARMACYen_US
dc.titleFake drugs: A survey of healthcare providers in Lagos State, Nigeria.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
NigerJBasicClinSci_2017_14_2_137_216051 - Fake Drugs Survey.pdf
Size:
1.13 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Clinical Pharmacy and Biopharmacy- Scholarly Publications